News last update:7 Aug 2012

DSM and ADM settle patent dispute

DSM and ADM announced that they have reached an agreement in a patent infringement dispute concerning DSM's US Patents 5,648,261 and 5,879,927 and ADM's Ecotone® Phaffia Astaxathin product.

Under the terms of the parties' agreement, ADM has entered into a license agreement with DSM and will continue to provide the Ecotone® product to the market. The financial terms of the agreement were not disclosed.

Wim Klop, DSM's General Manager of Intellectual Property, noted that "DSM values its significant intellectual property portfolio and it is pleased that a settlement was reached with ADM."

For regular updates on feed news subscribe here to our free newsletter

Editor AllAboutFeed

Or register to be able to comment.